glp 1 sites GLP-1 Medications Infographic glp1 injection sites - arm

Promotes Lean Muscle & Fat Reduction*

A retrospective disproportionality analysis was conducted using the reporting odds ratio (ROR) on FAERS data (20042024), with Bayesian confidence propagation neural network (BCPNN) employed for sensitivity analysis

Hear how GLP-1s actually perform in real-world populations and how they impact costs.

Provides safe, affordable medicine or medication with transparent low prices.

Today, we announced our investigational glucagon/GLP-1 dual receptor agonist achieved key measures of success at 48 weeks in our IMPACT Phase 2b trial and recent interactions with the FDA have resulted in alignment on the parameters for a registrational Phase 3 trial